Can Fite Biofarma Ltd (CANF)
2.40
+0.16
(+7.27%)
USD |
NYAM |
May 20, 15:01
Can Fite Biofarma Cash from Operations (Annual): -8.44M for Dec. 31, 2023
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -8.44M |
| December 31, 2022 | -10.80M |
| December 31, 2021 | -9.858M |
| December 31, 2020 | -12.06M |
| December 31, 2019 | -11.08M |
| December 31, 2018 | -4.155M |
| December 31, 2017 | -8.972M |
| Date | Value |
|---|---|
| December 31, 2016 | -8.714M |
| December 31, 2015 | -4.652M |
| December 31, 2014 | -7.327M |
| December 31, 2013 | -8.631M |
| December 31, 2012 | -4.348M |
| December 31, 2011 | -5.496M |
| December 31, 2010 | -3.655M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Annual) Range, Past 5 Years
-12.06M
Minimum
2020
-8.44M
Maximum
2023
-10.45M
Average
-10.80M
Median
2022
Cash from Operations (Annual) Benchmarks
| Compugen Ltd | -35.89M |
| Pluri Inc | -22.86M |
| BioLine Rx Ltd | -22.61M |
| XTL Biopharmaceuticals Ltd | -0.707M |
| BiomX Inc | -21.29M |